Linked Life Data

17982196

Source:http://linkedlifedata.com/resource/pubmed/id/17982196

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2007-11-5
pubmed:abstractText
Those who have already suffered from bone fractures have been found to have lower serum vitamin K (VK) concentrations than age-matched controls. Also in dialysis patients, serum VK(1) concentration are reported to be significantly lower in patients with previous fractures compared to those without. In most studies, there are no significant changes in the serum Ca, P, and intact PTH levels during the VK administration in dialysis patients. Investigation of the changes in metabolic bone markers, such as bone specific alkaline phosphatase (BAP) , during the VK therapy has yielded various results. Although the reason for these discrepancy is not well understood, it may be attributed to the differences in clinical features, including parathyroid function of the patients and to the differences in VK administered.
pubmed:language
jpn
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0917-5857
pubmed:author
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1745-50
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
[Renal osteodystrophy and vitamin K. Vitamin K and dialysis].
pubmed:affiliation
Shirasagi Clinic.
pubmed:publicationType
Journal Article, English Abstract, Review